cilengitide has been researched along with Neoplasm Metastasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, N; Takagi, S | 1 |
| Chakravarti, A; Huebner, A; Ibrahim, A; Lautenschlaeger, T; Li, B; Meng, W; Peereboom, D; Perry, J; White, J | 1 |
| Al-Hawary, M; Bradley, DA; Chen, A; Cooney, KA; Daignault, S; Dipaola, RS; Doyle, G; Escara-Wilke, J; Gross, ME; Hussain, M; Keller, ET; Mathew, P; Pienta, KJ; Ryan, CJ; Small, E; Smith, DC; Stein, MN | 1 |
| Imaizumi, N; Kuonen, F; Monnier, Y; Rüegg, C | 1 |
| Bedikian, AY; Camacho, LH; Colevas, AD; Diwan, AH; Gallick, GE; Hwu, P; Johnson, MM; Joseph, RW; Kim, KB; Ng, CS; Papadopoulos, NE; Prieto, V; Reckeweg, A; Vardeleon, A; Wei, W; Wittemer, SM | 1 |
| Cheresh, DA; Gillies, SD; Jonczyk, A; Lode, HN; Moehler, T; Reisfeld, RA; Xiang, R | 1 |
2 trial(s) available for cilengitide and Neoplasm Metastasis
| Article | Year |
|---|---|
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Collagen Type I; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Peptides; Prostate-Specific Antigen; Prostatic Neoplasms; Snake Venoms; Time Factors; Treatment Outcome | 2011 |
A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Snake Venoms | 2012 |
4 other study(ies) available for cilengitide and Neoplasm Metastasis
| Article | Year |
|---|---|
[Cancer metastasis-related molecules and their targeted drugs].
Topics: Animals; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Denosumab; Humans; Integrins; Membrane Glycoproteins; Membrane Proteins; Molecular Targeted Therapy; Neoplasm Metastasis; Snake Venoms | 2012 |
In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin beta Chains; Integrin beta3; Neoplasm Metastasis; Snake Venoms | 2013 |
Radiation-induced modifications of the tumor microenvironment promote metastasis.
Topics: Angiogenesis Inhibitors; Cell Hypoxia; Cell Movement; Cell Proliferation; Cysteine-Rich Protein 61; Disease Progression; Endothelial Cells; Humans; Microvessels; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Receptors, Vitronectin; Snake Venoms; Tumor Microenvironment | 2011 |
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.
Topics: Animals; Antigens, CD; Colonic Neoplasms; Humans; Immunotherapy; Immunotoxins; Integrin alphaV; Interleukin-2; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Neuroblastoma; Peptides, Cyclic; Receptors, Vitronectin; Recombinant Fusion Proteins; Snake Venoms; Tumor Cells, Cultured | 1999 |